Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$502K Buy
1,993
+2
+0.1% +$430 0.42% 44
2026
Q1
$433K Buy
1,991
+102
+5% +$22.6K 0.42% 44
2025
Q4
$432K Buy
1,889
+12
+0.6% +$2.73K 0.44% 41
2025
Q3
$435K Sell
1,877
-5
-0.3% -$1.02K 0.46% 40
2025
Q2
$349K Buy
1,882
+15
+0.8% +$2.79K 0.4% 46
2025
Q1
$391K Sell
1,867
-52
-3% -$10.1K 0.48% 40
2024
Q4
$341K Buy
1,919
+15
+0.8% +$2.76K 0.42% 44
2024
Q3
$376K Buy
1,904
+26
+1% +$4.85K 0.39% 50
2024
Q2
$322K Sell
1,878
-599
-24% -$99.2K 0.33% 59
2024
Q1
$451K Buy
2,477
+5
+0.2% +$862 0.26% 67
2023
Q4
$383K Buy
2,472
+25
+1% +$3.65K 0.25% 69
2023
Q3
$365K Buy
2,447
+12
+0.5% +$1.76K 0.26% 66
2023
Q2
$333K Buy
2,435
+477
+24% +$69.9K 0.23% 68
2023
Q1
$323K Buy
1,958
+19
+1% +$2.9K 0.25% 66
2022
Q4
$295K Buy
1,939
+3
+0.2% +$460 0.23% 68
2022
Q3
$260K Buy
1,936
+3
+0.2% +$430 0.23% 63
2022
Q2
$297K Buy
1,933
+326
+20% +$49.8K 0.24% 63
2022
Q1
$253K Buy
1,607
+3
+0.2% +$436 0.2% 71
2021
Q4
$232K Buy
+1,604
New +$189K 0.18% 73

Other funds holding ABBV

ETF Store's ABBV Position: Q2 2026 in Review

ETF Store increased its AbbVie (ABBV) stake by 0.1% in Q2 2026, buying an estimated $430 and bringing the position to 1,993 shares worth $502K. The position accounts for 0.42% of the portfolio, ranked #44.

ETF Store first reported a position in ABBV in Q4 2021 and has held it in 19 quarters since. 2,119 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • ETF Store held 1,993 shares of AbbVie worth $502K as of Q2 2026.
  • ETF Store bought 2 AbbVie shares in Q2 2026, an estimated $430.
  • AbbVie made up 0.42% of ETF Store's portfolio in Q2 2026, its #44 holding.
  • ETF Store first reported a position in AbbVie in Q4 2021 and has held it in 19 quarters since.
  • 2,119 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on ETF Store's 13F filing for Q2 2026, filed 29 Jul 2026.